Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow mesenchymal stem cell injection in children with cerebral palsy
IRCT20200502047277N5Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bone marrow mesenchymal stem cells in cerebral palsy (CP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Motor System Functioning, Balance Assessment and 3 more. Started Oct 2018; status: completed.
02
Drugs
bone marrow mesenchymal stem cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on IRCT20200502047277N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200502047277N5.